Head and Neck Cancer

Long-Lasting Responses Achieved with Keytruda® in Advanced Head and Neck Cancer (06-8-2016)

Treatment with the immune-stimulating agent, Keytruda® (pembrolizumab), provides impressive long-term outcomes for some patients with metastatic or recurrent head and neck cancer. These results were recently presented at the 2016 annual meeting of the... Continue Reading

Follow-Up Scans Reduce Need for Some Invasive Surgeries in Head and Neck Cancer (06-6-2016)

Utilizing PET-CT scans following treatment for patients with head and neck cancer that has spread to their lymph nodes significantly reduces the need for invasive follow-up surgery. These results were recently published in the New England Journal of Medicine. Patients... Continue Reading

More Evidence that PD-1 Inhibitors Improve Survival in Head and Neck Cancer (05-25-2016)

Results from a recent large trial indicate that treatment with the immunotherapy agent Opdivo® (nivolumab) nearly doubles the survival rate at one year in patients with advanced head and neck squamous cell carcinoma. These results prompted the United... Continue Reading

Better Outcomes in Oral Cancer with Surgery to Remove Lymph Nodes in Neck before Cancer Spreads (06-30-2015)

In early squamous-cell oral cancer, surgery to remove lymph nodes in the neck before cancer spreads may result in better outcomes. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago,... Continue Reading

Keytruda® Promising in Advanced Head and Neck Cancer (06-8-2015)

The immunotherapy Keytruda® (pembrolizumab) appears active in the treatment of advanced squamous cell head and neck cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois)... Continue Reading

Medical and dental centers throughout U.S. will take part in 18th annual OHANCAW®, April 12-18 (04-2-2015)

NEW YORK, NY, march 24, 2015 – Donnie Walsh, former President of the Indiana Pacers and New York Knicks and an oral cancer survivor, is urging Americans to get screened for cancer during the 18th annual Oral, Head & Neck Cancer Awareness Week®... Continue Reading

Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer (12-19-2014)

More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer,  developed at Massachusetts... Continue Reading

USPSTF Issues Final Recommendation on Oral Cancer Screening (12-18-2013)

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendation regarding screening for oral cancer. The task force issued an “I” statement, which means there is not enough evidence to make a definitive recommendation for or... Continue Reading

Swallowing Exercises and Oral Nutrition Are Critical During Treatment for Oral Cancer (10-7-2013)

Patients with oral cancers who receive oral nutrition and practice swallowing exercises throughout their treatment are able to maintain a significantly better long-term diet, according to the results of a study published in JAMA Otolaryngology Head and... Continue Reading

End-of-Life Care Remains Aggressive, Despite Patient Wishes (09-16-2013)

Although most patients with advanced cancer prefer hospice or palliative care that minimizes symptoms, many continue to receive aggressive treatment during their final weeks and months of life. In fact, elderly patients with advanced cancer often receive... Continue Reading

« Previous PageNext Page »